KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Working Capital Changes: 2009-2020

Historic Other Working Capital Changes for Thermo Fisher Scientific (TMO) over the last 11 years, with Dec 2020 value amounting to -$410.0 million.

  • Thermo Fisher Scientific's Other Working Capital Changes fell 322.83% to -$410.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.5 billion, marking a year-over-year decrease of 833.33%. This contributed to the annual value of $186.0 million for FY2024, which is 76.81% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Other Working Capital Changes stood at -$410.0 million for Q4 2020, which was up 44.52% from -$739.0 million recorded in Q3 2020.
  • Thermo Fisher Scientific's 5-year Other Working Capital Changes high stood at $443.0 million for Q1 2020, and its period low was -$746.0 million during Q2 2020.
  • Its 3-year average for Other Working Capital Changes is -$105.5 million, with a median of -$28.0 million in 2018.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 697.10% in 2017, then tumbled by 985.45% in 2019.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Other Working Capital Changes stood at $60.7 million in 2016, then slumped by 231.80% to -$80.0 million in 2017, then slumped by 146.25% to -$197.0 million in 2018, then surged by 193.40% to $184.0 million in 2019, then plummeted by 322.83% to -$410.0 million in 2020.
  • Its last three reported values are -$410.0 million in Q4 2020, -$739.0 million for Q3 2020, and -$746.0 million during Q2 2020.